Amplification of the steriodogenic factor 1 gene in childhood adrenocortical tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 2, 2005, Pages 615-619

  Figueiredo, Bonald C ^a   Cavalli, Luciane R ^b   Pianovski, Mara Albonei D ^a   Lalli, Enzo ^c   Sandrini, Romolo ^a   Ribeiro, Raul C ^d,e   Zambetti, Gerard ^d   DeLacerda, Luiz ^a   Rodrigues, Giovanna Assis ^a   Haddad, Bassem R ^b,f  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROIDOGENIC FACTOR 1; CELL RECEPTOR; DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR;

ADOLESCENT; ADRENAL CORTEX FUNCTION; ADRENAL CORTEX TUMOR; ADULT; AGED; ARTICLE; BRAZIL; CANCER INCIDENCE; CARCINOGENESIS; CHILDHOOD CANCER; CHROMOSOME 9Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE LOCATION; GENETIC ASSOCIATION; HUMAN; MALE; PRIORITY JOURNAL; SCHOOL CHILD; CHILD; CHROMOSOME 9; CHROMOSOME MAP; GENETICS; INCIDENCE;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; BRAZIL; CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; DNA-BINDING PROTEINS; GENE AMPLIFICATION; HOMEODOMAIN PROTEINS; HUMANS; INCIDENCE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 20044373088     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0942     Document Type: Article

References (36)

1. Sandrini R, Ribeiro RC, DeLacerda L 1997 Childhood adrenocortical tumors. J Clin Endocrinol Metab 82:2027-2031
2. Latronico AC, Chrousos GP 1997 Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab 82:1317-1324
3. Figueiredo BC, Stratakis CA, Sandrini R, DeLacerda L, Pianovsky MA, Giatzakis C, Young HM, Haddad BR 1999 Comparative genomic hybridization analysis of adrenocortical tumors of childhood. J Clin Endocrinol Metab 84:1116-1121
4. James LA, Kelsey AM, Birch JM, Varley JM 1999 Highly consistent genetic alterations in childhood adrenocortical tumours detected by comparative genomic hybridization. Br J Cancer 81:300-304
5. Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, Lichter P 2000 Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer 28: 145-152
6. Rice DA, Mouw AR, Bogerd A, Parker KL 1991 A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 5:1552-1561
7. Ikeda Y, Lala DS, Luo X, Kim E, Moisan MP, Parker KL 1993 Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Mol Endocrinol 7:852-860
8. Wong M, Ikeda Y, Luo X, Caron KM, Weber TJ, Swain A, Schimmer BP, Parker KL 1997 Steroidogenic factor 1 plays multiple roles in endocrine development and function. Recent Prog Horm Res 52:167-182
9. Parker KL, Schimmer BP 1997 Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev 18:361-377
10. Luo X, Ykeda Y, Parker KL 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490
11. Bland ML, Jamieson CA, Akana SF, Bornstein SR, Eisenhofer G, Dallman MF, Ingraham HA 2000 Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc Natl Acad Sci USA 97:114488-114493
12. Beuschlein F, Mutch C, Bavers DL, Ulrich-Lai YM, Engeland WC, Keegan C, Hammer GD 2002 Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 143:3122-3135
13. Bocian-Sobkowska J, Wozniak W, Malendowicz LK 1998 Postnatal involution of the human adrenal fetal zone: stereologic description and apoptosis. Endocr Res 24:969-973
14. Varley JM 2003 Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 21:313-320
15. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G, Cat I, Stratakis CA, Sandrini R 2001 An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA 98:9330-9335
16. Cullen KJ, Newkirk KA, Schumaker LM, Aldosari N, Rone JD, Haddad BR 2003 Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res 63:8097-8102
17. Haddad B, Pabon-Pena CR, Young H, Sun WH 1998 Assignment1 of STAT1 to human chromosome 2q32 by FISH and radiation hybrids. Cytogenet Cell Genet 83:58-59
18. Henry I, Grandjouan S, Couillin P, Barichard F, Huerre-Jeanplerre C, Glaser T, Philip T, Lenoir G, Chaussain JL, Junien C 1989 Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci USA 86:3247-3251
19. Henry I, Jeanpierre M, Couillin P, Barichard F, Serre JL, Journel H, Lamouroux A, Turleau C, de Grouchy J, Junien C 1989 Molecular definition of the 11p15.5 region involved in Beckwith-Wiedemann syndrome and probably in predisposition to adrenocortical carcinoma. Hum Genet 81:273-277
20. Yano T, Linehan M, Anglard P, Lerman MI, Daniel LN, Stein CA, Robertson CN, LaRocca R, Zbar B 1989 Genetic changes in human adrenocortical carcinomas. J Natl Cancer Inst 81:518-523
21. Beckers A, Abs R, Willems PJ, van der Auwera B, Kovacs K, Reznik M, Stevenaert A 1992 Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. J Clin Endocrinol Metab. 75:564-570
22. Albertson DG, Pinkel D 2003 Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 12(Spec 2):R145-R152
23. Henske EP, Short MP, Jozwiak S, Bovey CM, Ramlakhan S, Haines JL, Kwiatkowski DJ 1995 Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1. Ann Hum Genet 59:25-37
24. Johnson DW, Qumsiyeh M, Benkhalifa M, Marchuk DA 1995 Assignment of human transforming growth factor-β type I and type III receptor genes (TGFBR1 and TGFBR3) to 9q33-q34 and 1p32-p33, respectively. Genomics 28:356-357
25. Siemienski K, Peters N, Scheurich P, Wajant H 1997 Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosome 9q33-34. Gene 195:35-39
26. Chan P, Simon-Chazottes D, Mattei MG, Guenet JL, Salier JP 1994 Comparative mapping of lipocalin genes in human and mouse: the four genes for complement C8 γ chain, prostaglandin-D-synthase, oncogene-24p3, and progestagen-associated endometrial protein map to HSA9 and MMU2. Genomics 23:145-150
27. Michalkiewicz E, Sandrini R, Figueiredo B, Miranda EC, Caran E, Oliveira-Filho AG, Marques R, Pianovski MA, Lacerda L, Cristofani LM, Jenkins J, Rodriguez-Galindo C, Ribeiro RC 2004 Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 22:838-845
28. Bergada I, Venara M, Maglio S, Ciaccio M, Diez B, Bergada C, Chemes H 1996 Functional adrenal cortical tumors in pediatric patients: a clinicopathologic and immunohistochemical study of a long term follow-up series. Cancer 77:771-777
29. Driver CP, Birch J, Gough DC, Bruce J 1998 Adrenal cortical tumors in childhood. Pediatr Hematol Oncol 15:527-532
30. Teinturier C, Pauchard MS, Brugieres L, Landais P, Chaussain JL, Bougneres PF 1999 Clinical and prognostic aspects of adrenocortical neoplasms in childhood. Med Pediatr Oncol 32:106-111
31. Wolthers OD, Cameron FJ, Scheimberg I, Honour JW, Hindmarsh PC, Savage MO, Stanhope RG, Brook CG 1999 Androgen secreting adrenocortical tumours. Arch Dis Child 80:46-50
32. Achermann JC, Ito M, Ito M, Hindmarsh PC, Jameson JL 1999 A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22:125-126
33. Botrugno OA, Fayard E, Annicotte J-S, Haby C, Brennan T, Wendling O, Tanaka T, Kodama T, Thomas W, Auwerx J, Schoonjans K 2004 Synergy between LRH-1 and β-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell 15:499-509
34. DiGiammarino EL, Lee AS, Cadwell C, Zhang W, Bothner B, Ribeiro RC, Zambetti G, Kriwacki RW 2002 A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat Struct Biol 9:12-16
35. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD 1992 Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935
36. Volgestein B, Kinzler KW 1993 The multistep nature of cancer. Trends Genet 9:138-141